glp-1 receptor agonist dry eye Unlocking the potential of agonists in ocular therapeutics: from molecular pathways to clinical impact Targeting GLP-1, GIP & GCG
Description
Despite rising usage, cost continues to limit long-term adherence
Incretins slow gastric emptying and also curb post-meal glucagon release, decreasing post prandial glucose spikes
A well-built interface should make it simple to build multiples, tweak stakes, and understand potential returns at a glance
Rodriguez R, Moreno M, Lee AY, Godoy-Lugo JA, Nakano D, Nishiyama A, et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy [Internet]
Insulin resistance in T1D could also be related to the insulin administration route
